Hospital Acquired Infections Testing Kits Market Dynamics 2026: Future Outlook and Key Insights
Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company
Starting from its 2026 valuation, what market size is the Hospital Acquired Infections Testing Kits Market expected to reach by 2030?
The hospital acquired infections testing kits market size has demonstrated significant expansion in recent years. It is anticipated to increase from $4.79 billion in 2025 to $5.19 billion in 2026, with a compound annual growth rate (CAGR) of 8.5%. This historical growth can be attributed to several factors including increased hospital infection surveillance, the rising prevalence of antibiotic-resistant pathogens, the expansion of clinical microbiology laboratories, the implementation of stringent infection control protocols, and the greater availability of molecular diagnostic tools.
The hospital acquired infections testing kits market size is projected to experience robust expansion over the coming years. This market is anticipated to reach $7.2 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.5%. Factors contributing to this growth during the forecast period include a heightened emphasis on early detection of infections, increased investments in hospital safety infrastructure, wider adoption of rapid testing, a growing need for automated diagnostic processes, and innovations in molecular diagnostics technology. Key trends defining the forecast period involve the rising uptake of rapid diagnostic test kits, increased application of molecular testing for HAIs, greater integration of automated diagnostic tools, the broadening scope of point-of-care infection testing, and a stronger focus on identifying multiple pathogens.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2469&type=smp
What Drivers Are Driving Adoption Within The Hospital Acquired Infections Testing Kits Market?
The expanding presence of healthcare settings is projected to fuel the advancement of the hospital-acquired infections testing kits market in the future. Healthcare settings encompass a range of facilities and services, such as acute care hospitals, urgent care centers, rehabilitation facilities, nursing homes, and long-term care facilities, which together provide extensive healthcare options. These hospital-acquired infections testing kits are crucial instruments for identifying and averting nosocomial infections, thereby improving patient safety within healthcare facilities. An example of this trend is observed in May 2023, when the American Hospital Association, a US-based healthcare industry trade group, reported a substantial rise in the total number of hospitals in the U.S. region, increasing from 6,093 in 2022 to 60,129 in 2023. Moreover, community hospital admissions also climbed from 31,393,318 in 2022 to 31,967,073 in 2023. Consequently, the increasing volume of healthcare settings propels the hospital-acquired infections testing kits market.
What Segments Are Included Within The Hospital Acquired Infections Testing Kits Market?
The hospital acquired infections testing kits market covered in this report is segmented –
1) By Product: Consumables And Reagents, Instruments
2) By Test Type: Pneumoia Infection, Urinary Track Infection, Blood Stream Associated Infection, Surgical Site Infection, MRSA infection, Others
3) By Pathogen Type: Viral, Bacterial, Fungal
4) By Application: Drug Resistance Testing, Disease Testing
Subsegments:
1) By Consumables and Reagents: Culture Media (Used for isolating and identifying pathogens), Reagents For Molecular Testing (Includes PCR reagents and kits for detecting specific pathogens), Test Kits (Rapid tests and other kits designed for various infections), Other Consumables (Includes swabs, sample collection devices, and preservation solutions)
2) By Instruments: Automated Analyzers (Equipment used for blood culture analysis and identification of pathogens), Molecular Diagnostic Instruments (Machines used for PCR and other molecular testing methods), Microscopes (Used for the identification of pathogens in samples), Incubators And Growth Chambers (For culturing samples under controlled conditions)
Which Trends Are Influencing The Development Of The Hospital Acquired Infections Testing Kits Market?
Leading companies operating in the hospital-acquired infections (HAI) testing kits market are focusing on developing advanced point-of-care antimicrobial susceptibility testing (AST) solutions to enable rapid diagnosis, guide targeted therapy, and combat antimicrobial resistance (AMR). This point-of-care AST leverages proprietary microfluidic technology to quickly detect bacterial presence and assess antibiotic effectiveness directly from patient urine samples, thereby reducing diagnostic delays and improving treatment decisions. For instance, in June 2023, Sysmex Corporation, a Japan-based diagnostics company, introduced the world’s first point-of-care testing system in Europe capable of performing antimicrobial susceptibility testing in just 30 minutes. Utilizing a microfluidic-based AST approach for patients suspected of urinary tract infections, the system significantly reduces turnaround time and supports antimicrobial stewardship in primary care settings by enabling timely and informed antibiotic use, consequently contributing to global efforts to curb AMR.
Who Are The Top-Performing Companies In The Hospital Acquired Infections Testing Kits Market In Recent Years?
Major companies operating in the hospital acquired infections testing kits market are Becton Dickinson and Company, Abbott Laboratories, Cepheid, F. Hoffmann-La Roche Ltd, STERIS plc, QIAGEN, Meridian Bioscience Inc., BioMérieux SA, GE Healthcare, Seegene, SD Biosensor, Fujirebio, Sysmex Corporation, Getein Biotech, Hangzhou Biotest Biotech, AmonMed Biotechnology, Beijing Tigsun Diagnostics, Hunan Lituo Biotechnology, ImmunoScience, Vivacheck Lab
Access The Complete Report For Deeper Market Insights:
Which Region Currently Holds The Largest Share Of The Hospital Acquired Infections Testing Kits Market?
North America was the largest region in the hospital-acquired infections testing kits market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hospital acquired infections testing kits market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Hospital Acquired Infections Testing Kits Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=2469&type=smp
Browse Through More Reports Similar to the Global Hospital Acquired Infections Testing Kits Market 2026, By The Business Research Company
Viral Diagnostic Test Kits Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/viral-diagnostic-test-kits-global-market-report
Infection Control Supplies Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/infection-control-supplies-global-market-report
Hospital Acquired Infection Control Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
